Is Adding IgM Antibody to Polymerase Chain Reaction Testing Useful for COVID-19 Travel Screening?

Yi, Xin; Chan, Clarence W; Yeo, Kiang-Teck J

Yi, Xin; Chan, Clarence W; Yeo, Kiang-Teck J.

Yi X; Department of Pathology and Genomic Medicine, Weill Cornell Medical College, Houston Methodist Hospital and Research Institute, Houston, TX.
Chan CW; Department of Pathology, University of Chicago, Chicago, IL.
Yeo KJ; Department of Pathology, University of Chicago, Chicago, IL.

Am J Clin Pathol ; 155(3): 321-323, 2021 02 11.

Article in English | MEDLINE | ID: covidwho-1007436

Subject(s)

Antibodies, Viral/blood; COVID-19 Nucleic Acid Testing; COVID-19 Serological Testing/methods; COVID-19/diagnosis; Communicable Diseases, Imported/prevention & control; Immunoglobulin M/blood; COVID-19/blood; Humans; SARS-CoV-2; Travel Medicine/methods

Keywords

COVID-19; Coronavirus; Double-negative test; IgM and IgG antibody; Nucleic acid test; Point-of-care test; RT-PCR; SARS-CoV-2; Travel screening

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Immunoglobulin M / Communicable Diseases, Imported / COVID-19 Nucleic Acid Testing / COVID-19 Serological Testing / COVID-19 / Antibodies, Viral Type of study: Diagnostic study Limits: Humans Language: English Journal: Am J Clin Pathol Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google